Compare Mekophar Chemical Pharmaceutical JSC with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
VND 273,809 Million ()
17.00
NA
4.61%
-0.09
-0.83%
0.22
Revenue and Profits:
Net Sales:
226,268 Million
(Quarterly Results - Sep 2025)
Net Profit:
-9,689 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.5%
0%
12.5%
6 Months
25.5%
0%
25.5%
1 Year
3.96%
0%
3.96%
2 Years
16.67%
0%
16.67%
3 Years
16.67%
0%
16.67%
4 Years
-55.32%
0%
-55.32%
5 Years
0%
0%
0.0%
Mekophar Chemical Pharmaceutical JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.73%
EBIT Growth (5y)
-184.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
194,901.75
Tax Ratio
36.50%
Dividend Payout Ratio
30.98%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.55%
ROE (avg)
11.43%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
0.22
EV to EBIT
-3.86
EV to EBITDA
19.07
EV to Capital Employed
0.14
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
4.70%
ROCE (Latest)
-3.52%
ROE (Latest)
1.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
226,268.10
204,877.60
10.44%
Operating Profit (PBDIT) excl Other Income
-15,702.30
-4,469.40
-251.33%
Interest
0.00
7.40
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-9,689.30
6,519.20
-248.63%
Operating Profit Margin (Excl OI)
-69.40%
-79.70%
1.03%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 10.44% vs -1.71% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -248.63% vs 163.50% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
919,577.50
904,746.60
1.64%
Operating Profit (PBDIT) excl Other Income
38,882.00
55,542.10
-30.00%
Interest
0.00
500.90
-100.00%
Exceptional Items
0.00
17,366.80
-100.00%
Consolidate Net Profit
40,785.30
21,161.10
92.74%
Operating Profit Margin (Excl OI)
-9.30%
7.80%
-1.71%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
About Mekophar Chemical Pharmaceutical JSC 
Mekophar Chemical Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Mekophar Chemical Pharmaceutical Joint-Stock Company (Mekophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, trades and distributes drugs, as well as chemicals and raw materials for drug manufacturing. It also manufactures and trades medical equipment and packaging, such as plastic bottles, carton boxes and paper containers. In addition, Mekophar is active in office and apartment leasing, as well as cosmetic manufacturing and trading.
Company Coordinates 
Company Details
297/5 Ly Thuong Kiet, Quan 11 , HO CHI MINH None : None
Registrar Details






